38,768 Shares in HCA Healthcare, Inc. $HCA Purchased by Mirae Asset Global Investments Co. Ltd.

by · The Markets Daily

Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 38,768 shares of the company’s stock, valued at approximately $16,544,000.

A number of other hedge funds have also bought and sold shares of HCA. MidFirst Bank acquired a new stake in HCA Healthcare during the 2nd quarter worth about $28,000. Clearstead Trust LLC acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at about $29,000. Latitude Advisors LLC acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at about $32,000. Cedar Mountain Advisors LLC bought a new stake in shares of HCA Healthcare during the 1st quarter valued at about $33,000. Finally, Delos Wealth Advisors LLC acquired a new stake in HCA Healthcare during the second quarter worth approximately $35,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 1.1%

HCA opened at $462.52 on Wednesday. HCA Healthcare, Inc. has a 1-year low of $353.99 and a 1-year high of $556.52. The company has a market cap of $96.62 billion, a price-to-earnings ratio of 15.33, a PEG ratio of 1.56 and a beta of 1.11. The company’s fifty day moving average price is $438.88 and its two-hundred day moving average price is $444.76.

HCA Healthcare (NYSE:HCA – Get Free Report) last issued its quarterly earnings data on Tuesday, October 27th. The company reported $7.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.65 by $0.57. The firm had revenue of $19.85 billion during the quarter, compared to analysts’ expectations of $19.33 billion. HCA Healthcare had a net margin of 8.61% and a negative return on equity of 198.52%. During the same period last year, the company earned $6.96 earnings per share. The business’s revenue was up 3.6% on a year-over-year basis. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 30.15 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 29th. Stockholders of record on Tuesday, December 15th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, December 15th. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio is 10.34%.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

  • Positive Sentiment: Truist reaffirmed its “Buy” rating and raised its price target to $510 from $495, suggesting confidence in HCA’s prospects. Read More.
  • Positive Sentiment: HCA plans a $300 million hospital in Cape Coral, Florida, with $31 million in city incentives. The project could support future capacity and growth, though it also entails significant investment. Cape Coral hospital article
  • Neutral Sentiment: An HCA subsidiary plans to issue senior notes. The financing may support corporate needs, but the available report does not provide terms or indicate how much debt will be added. Senior notes offering
  • Negative Sentiment: A report on HCA’s third-quarter payer mix highlights an estimated $400 million cost burden associated with a shift toward uninsured patients. Higher uncompensated-care costs could weigh on margins. Q3 revenue by payer article
  • Negative Sentiment: Pomerantz LLP said it is investigating potential claims on behalf of HCA investors. An investigation is not a finding of wrongdoing, but the announcement adds legal and reputational uncertainty. Investor investigation announcement
  • Negative Sentiment: A reported data breach affected about 55,000 people, creating potential privacy, remediation and reputational risks. Data breach report

Analyst Ratings Changes

Several equities analysts have issued reports on HCA shares. BMO Capital Markets assumed coverage on HCA Healthcare in a research note on Tuesday, September 22nd. They issued an “outperform” rating and a $495.00 price target on the stock. Robert W. Baird boosted their target price on shares of HCA Healthcare from $393.00 to $409.00 and gave the company a “neutral” rating in a research report on Wednesday, October 28th. Weiss Ratings raised shares of HCA Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Barclays raised their price target on shares of HCA Healthcare from $387.00 to $401.00 and gave the stock an “equal weight” rating in a report on Thursday, October 29th. Finally, KeyCorp upped their price objective on shares of HCA Healthcare from $435.00 to $490.00 and gave the company an “overweight” rating in a report on Wednesday, October 28th. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $480.13.

Get Our Latest Stock Report on HCA Healthcare

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.

Read More